TABLE 3.
Effect of BSTN1 on hepatic lipid profile of treated and untreated rats.
| Parameters | Normal control | HFD control | BSTN1-1.25 mg | BSTN1-2.5 mg | BSTN1-5 mg | ORL-5 mg |
|---|---|---|---|---|---|---|
| TC (mg/dl) | 61.37 ± 5.3 | 118.2 ± 7.4# | 111.6 ± 12.2* | 91.3 ± 11.0** | 67.6 ± 8.0*** | 62.9 ± 7.5*** |
| TGL (mg/dl) | 84.9 ± 2.7 | 156.1 ± 7.7# | 127.7 ± 1.3* | 97.8 ± 2.5** | 79.07 ± 1.7*** | 81.6 ± 2.1*** |
| FFA (mg/g) | 69.34 ± 3.0 | 125.8 ± 2.3# | 104.9 ± 3.0* | 84.1 ± 2.3** | 70.3 ± 2.7*** | 62.3 ± 2.1*** |
The data is expressed as the mean ± SD, n = 6. # p < 0.001 indicates significant difference between HFD control and normal control. *, ** and*** indicate significant difference between HFD control and treated groups at p < 0.05, p < 0.01, and p < 0.001, respectively. TC, total cholesterol; TGL, triglycerides and FFA, free fatty acid.